FGF23 and chronic kidney disease: Isakova et al. investigated the synergic effect of phosphate binding and phosphate restriction on FGF23 serum levels in a single-blinded, placebo-controlled, 3-month study including CKD patients at stage 3 and 4 and with normal phosphate serum levels.